Olaparib in the maintenance treatment of platinum-sensitive relapse of BRCA mutant ovarian cancer in routine clinical practice: first results of observational study in Russian patients

Olaparib in the maintenance treatment of platinum-sensitive relapse of BRCA mutant ovarian cancer in routine clinical practice: first results of observational study in Russian patients

Background and aims. There is no data on olaparib efficacy and safety in Russian routine clinical practice. Methods. We analysed the 30 consecutive patients who received maintenance olaparib treatment for platinum-sensitive relapse (PSR) of ovarian or fallopian tube cancer in Russian Cancer Centers....

Full description

Bibliographic Details
Main Authors: E V Artamonova, E I Kovalenko, A V Snegovoy, A A Aksarin, T A Anciferova, A V Belonogov, E V Bilan, S N Bilenko, I M Varvus, E A Gorkovenko, R F Enikeev, A M Ermolaeva, L V Kramskaya, I B Kononenko, A P Pechenyy, S Z Safina, T V Chupriyanova, G G Chuhua, A I Shemyakina, E V Shikina
Format: Article
Language:Russian
Published: IP Habib O.N. 2018-09-01
Series:Современная онкология
Subjects:
real world experience
ovarian cancer
olaparib
Online Access:https://modernonco.orscience.ru/1815-1434/article/viewFile/29560/pdf

Internet

https://modernonco.orscience.ru/1815-1434/article/viewFile/29560/pdf

Similar Items